MedPath

Dexmedetomidine will be compared with Nalbuphine as an add-on drug to the local anaesthetic Ropivacaine for intraperitoneal instillation in patients undergoing Laparoscopic gall bladder removal surgery.

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/07/055724
Lead Sponsor
Dr Shubham Gupta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA (American Society of Anesthesiologists) grade I and II

Either sex

Age group of 18-60

Elective laparoscopic cholecystectomy

Exclusion Criteria

Patient who will not give consent.

ASA grade III and IV.

Allergy to study drug.

Second and third degree of heart block.

BMI (body mass index) >30kg/m.Pregnancy and lactation.

Opioid addiction.

Conversion of laparoscopic to open cholecystectomy.

Patients on anti-epileptic medication.

Drain inserted at surgical site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath